 |
 |
 |
 |
 |
 |
 American Urological Association 2010 Annual Meeting 6th Annual Medical Innovation Summit Predictive Biosciences’ President and CEO, Peter Klemm, Ph.D. and Predictive Board Member, Michael Greeley of Flybridge Capital Partners, will participate in a session titled, “Venture Investing from the Inside Out: An Issues-Oriented, Contemporary Case Study” on November 11, 2008 at 1:45 p.m. Cambridge Healthtech Institute’s Inaugural Predictive Biosciences CTO Anthony P. Shuber to present “Utilizing Urinary Protein Biomarkers for Managing Cancer Survivors” TriMark Cancer Biomarkers Conference 2008 Predictive Biosciences CTO Anthony P. Shuber to present “Utilizing Urinary Protein Biomarkers for Cancer Management” AACR Annual Meeting 2008 Predictive Biosciences will present a poster “Development of a Novel Intervention Diagnostic Assay for Managing Bladder Cancer Survivors Using Urinary Biomarkers” Molecular Medicine Tri Conference Predictive Biosciences will present a poster “Development of a Novel Intervention Diagnostic Assay for Managing Bladder Cancer Survivors Using Urinary Biomarkers” MIT Enterprise Forum Innovation Summit 2008 Predictive Biosciences' VP of Business Development Eugene Chiu was on the panel for "Drugs: Commercializing the Bench" on February 7th at 11:20 am GTCBio’s 2008 Oncology Biomarkers Conference Predictive Biosciences’ CTO Anthony P. Shuber presented on Tuesday Jan 15th at 9:15 am |